Tandem Diabetes Care (TNDM) Total Liabilities (2013 - 2026)

Tandem Diabetes Care has reported Total Liabilities for 14 years, with the latest figure at $1.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 33.14% year-over-year to $1.0 billion; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (up 33.14% YoY), and the FY2025 full-year result was $725.9 million, up 3.03% from the prior year.
• Total Liabilities for Q1 2026 stood at $1.0 billion, up from $725.9 million in the prior quarter.
• The five-year high for Total Liabilities was $1.0 billion in Q1 2026, with the low at $577.9 million in Q1 2022.
• Historically, Total Liabilities has averaged $689.7 million across 5 years, with a median of $698.0 million in 2024.
• Annual changes were most pronounced in 2022 — Total Liabilities soared 35.84% — and 2023, when it grew 0.03%.
• Tandem Diabetes Care's Total Liabilities stood at $612.8 million in 2022, then gained by 4.27% to $639.0 million in 2023, then advanced by 10.26% to $704.6 million in 2024, then grew by 3.03% to $725.9 million in 2025, then surged by 40.64% to $1.0 billion in 2026.
• The last three Total Liabilities figures came in at $1.0 billion (Q1 2026), $725.9 million (Q4 2025), and $741.7 million (Q3 2025), per Business Quant data.